Day: July 3, 2024

TORONTO, July 03, 2024 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (the “Company” or “Doré Copper“) (TSXV: DCMC; OTCQB: DRCMF; FRA: DCM) is pleased to announce it has entered into an agreement with SOQUEM to acquire a 56.41% interest in a group of contiguous claims (the “Claim Group”) located immediately north and east of its flagship high-grade Corner Bay copper project in the Chibougamau mining camp, approximately 55 kilometers by road from Chibougamau, Québec. The Claim Group totals 17 claims covering an area of 446 ha within Dore Copper’s 100% owned Corner Bay-Devlin Property (5,446 ha) (Figure 1). The Claim Group has seen historical exploration during the 1970’s with 36 diamond drill holes totaling approximately 7,610 meters. Further exploration activities was carried out by SOQUEM between 1992...

VANCOUVER, BC, July 03, 2024 (GLOBE NEWSWIRE) — AMERICAN SALARS LITHIUM INC. (“AMERICAN SALARS” OR THE “COMPANY”) (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY) announces the Company is registering a mining company in Argentina operating under the name “American Salars Pocitos SA”, a 100% owned subsidiary of American Salars, a crucial next step as the Company matures from the acquisition, discovery and delineation of inferred mineral resources, to the establishment of measured and indicated resources, economics, environmental, tax efficiency, development and the potential for pilot and eventual commercial production at the Pocitos 1 lithium project (“Pocitos 1”). Upon completion of the option of the Candela II project on Salar de Incahuasi the Company will register an additional Argentina subsidiary to hold...

DNA PLC STOCK EXCHANGE RELEASE 3 JULY 2024 AT 15:20 EEST DNA Plc’s Finnish network infrastructure business, which is conducted by the company’s subsidiary, DNA Tower Finland Oy, is being transferred to a limited company that is to be founded as part of DNA’s partial demerger, Telenor Towers Finland Oy. The partial demerger is planned to take place on 31 December 2024. This is an internal restructuring within Telenor Group and will not impact DNA’s operations. Media enquiries:DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi DNA is one of the leading telecommunications companies in Finland. Our mission is to connect you to what matters most. We offer connections, services and devices for homes and workplaces, contributing to the digitalisation of society. DNA’s customers have been among the most active users of...

Following the Company’s recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial BRAINTREE, Mass., July 03, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board approval and signed a Clinical Trial Agreement with Baptist Hospital of Miami, which includes Miami Cardiac & Vascular Institute and Miami Cancer Institute.   This is the second announced site that will participate in the clinical trial for Microbot’s LIBERTY as part of its Investigational Device Exemption (“IDE”).   The Company had recently announced Brigham and Women’s Hospital as another participating site. The principal investigator...

MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will release its financial results for the second quarter ended June 30, 2024 via news release on Thursday, July 25, 2024 after market close. The company will host a webcast with Alain Bédard, Chairman, President and Chief Executive Officer, on Friday, July 26, 2024 at 8:30 AM Eastern Time, to discuss results. Webcast Details:Date: Friday, July 26, 2024 Time: 8:30 a.m. Eastern Time Live webcast & replay: Presentations & Reports within the Investors section of the Company websiteABOUT TFI INTERNATIONALTFI International Inc. is a North American leader in the transportation and logistics industry, operating across the United States, Canada...

Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces details for an upcoming oral presentation at the European Society for Medical Oncology (ESMO) Virtual Plenary session on July 11, 2024, featuring new clinical data in patients with negative PD-L1 expression (Cohort B) in the TACTI-003 (KEYNOTE-PNC-34) Phase IIb trial, and a webcast to discuss these clinical results. ESMO Virtual Plenaries are monthly presentations of the latest, original scientific data, including “Phase II trials which demonstrate remarkable therapeutic benefit, scientific insight or progress in an...

Vancouver, British Columbia, July 03, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1), a multi-jurisdictional, polymetallic exploration company focused on supporting the global transition to clean energy, is pleased to announce the signing of the definitive option agreement dated July 2, 2024 (“Agreement”) between the Company, Fulcrum Metals Plc. (“Fulcrum”, AIM:FMET) and Fulcrum Metals (Canada) Ltd. (“Fulcrum Canada”), a wholly-owned subsidiary of Fulcrum, pursuant to which the Company will obtain a four-year option (the “Option”) to acquire a 100% interest in Fulcrum’s uranium portfolio of exploration licences (the “Licences”) located in northern Saskatchewan, Canada and collectively encompassing 596.71 km2 of highly prospective ground for a uranium discovery. Pursuant to...